事件

Working in BioTech: Going Over To The Dark Side or Seeing The Light? STEMCELL's founder and CEO Dr. Allen Eaves presents his insights on entrepreneurship in today's biotechnology climate and its role in driving scientific advancement.

Standardization of the Hematopoietic Progenitor Assay Training Course Apply now to reserve your space in our two-day training course specifically targeted to participants working with human hematopoietic samples.

iPS Cells to Neural Progenitors Training Course: Reprogramming, Maintenance and Differentiation Apply now to reserve your space in our three-day course that covers the entire workflow of reprogramming somatic cells to induced pluripotent stem (iPS) cells, the maintenance of human embryonic stem (ES) and iPS cells and their differentiation into neural progenitor cells (NPCs).

Applications of the Hematopoietic Progenitor Assay Training Course Apply now to reserve your space in our two-day training course focusing on hematopoietic progenitor assays for human, mouse, rat and dog samples with an emphasis on applying the colony forming unit (CFU) assay to your research.

Keystone Symposia - Cancer Immunotherapy: Immunity and Immunosuppression Meet Target Therapies (J6) Visit STEMCELL Technologies during Poster Session 2 in the Pacific Ballroom.

BCTECH Summit STEMCELL Technologies is British Columbia's largest biotech company and you can come visit our booth on both days of the #BCTECH Summit in the Vancouver Convention Centre.